-
公开(公告)号:US20170296652A1
公开(公告)日:2017-10-19
申请号:US15509605
申请日:2015-09-17
Applicant: STC.UNM
Inventor: Bridget S. Wilson , Diane Lidke , Lydia Tapia , Mark Schulyer , Avanika Mahajan
IPC: A61K39/35 , C07K14/435 , C07K14/415
CPC classification number: A61K39/35 , A61K2039/577 , C07K14/415 , C07K14/43509 , C07K14/4702
Abstract: This disclosure describes recombinant hypoallergens and methods of treating allergy that involve administering a recombinant hypoallergen to a subject. Generally, the recombinant hypoallergen includes at least one amino acid modification compared to a corresponding wildtype allergen. As a result, the recombinant hypoallergen binds to IgE that specifically binds to the allergen, but induces release of histamine from basophils to a degree less than the wildtype allergen.
-
公开(公告)号:US20170296108A1
公开(公告)日:2017-10-19
申请号:US15489828
申请日:2017-04-18
Applicant: STC.UNM
Inventor: John B. Plumley , Erin D. Milligan , Marek Osinski
IPC: A61B5/1455 , A61B5/00 , A61B5/1459 , G01N33/58 , A61B5/1473
CPC classification number: A61B5/1455 , A61B5/1459 , A61B5/14735 , A61B5/4058 , A61B5/6852 , A61B5/6877 , A61B2562/0233 , A61B2562/0285 , G01N33/588
Abstract: The invention provides a quantum dot (QD) modified optical fiber-based biosensor which characterizes matrix metalloproteinase (MMP) enzyme activity at pain signaling sites in the central nervous system (CNS) in vivo. Related systems and peptide biomarker screening methods are also provided.
-
公开(公告)号:US20170234673A1
公开(公告)日:2017-08-17
申请号:US15583350
申请日:2017-05-01
Applicant: STC.UNM
Inventor: Scott S. Sibbett
CPC classification number: G06F3/0414 , G01L1/205
Abstract: A pliable pressure sensitive sensor device and method of making the same is provided. The sensor includes first and second pliable protective layers, which cover sets of conductive fibers that spatially separated by an electrically conductive pliable layer, which deforms in response to a pressure event. The fiber sets form a grid pattern and are in electrical communication with sets of electrical contacts located in predetermined locations along the fibers. In response to a pressure event in proximity to the contact, the pliable layer deforms and increases the amount of surface area in contact with an electrical contact whereby an electrical resistance at an individual electrical contact decreases in response to the pressure event.
-
224.
公开(公告)号:US20170232115A1
公开(公告)日:2017-08-17
申请号:US15380962
申请日:2016-12-15
Applicant: STC.UNM , Sandia Corporation
Inventor: Carlee Erin Ashley , C. Jeffrey Brinker , Eric C. Carnes , Mohammed Houman Fekrazad , Linda A. Felton , Oscar Negrete , David Patrick Padilla , Brian S. Wilkinson , Dan C. Wilkinson , Cheryl L. Willman
IPC: A61K49/00 , A61K33/24 , A61K31/513 , C12N15/113 , A61K38/45 , A61K31/506 , A61K38/47 , A61K31/465 , A61K31/192 , A61K31/704 , A61K48/00
CPC classification number: A61K48/0008 , A61K9/0014 , A61K9/107 , A61K9/1271 , A61K9/5078 , A61K31/192 , A61K31/465 , A61K31/506 , A61K31/513 , A61K31/704 , A61K31/7088 , A61K31/7105 , A61K31/713 , A61K33/24 , A61K38/00 , A61K38/17 , A61K38/45 , A61K38/47 , A61K45/06 , A61K47/6923 , A61K49/0082 , A61K49/0423 , B82Y5/00 , C07K7/06 , C07K2319/00 , C12N15/113 , C12N15/1131 , C12N15/88 , C12N2310/14 , C12N2320/32 , C12N2810/40 , C12Y204/02036 , C12Y302/02022 , A61K2300/00
Abstract: The present invention is directed to protocells for specific targeting of hepatocellular and other cancer cells which comprise a nanoporous silica core with a supported lipid bilayer; at least one agent which facilitates cancer cell death (such as a traditional small molecule, a macromolecular cargo (e.g. siRNA or a protein toxin such as ricin toxin A-chain or diphtheria toxin A-chain) and/or a histone-packaged plasmid DNA disposed within the nanoporous silica core (preferably supercoiled in order to more efficiently package the DNA into protocells) which is optionally modified with a nuclear localization sequence to assist in localizing protocells within the nucleus of the cancer cell and the ability to express peptides involved in therapy (apoptosis/cell death) of the cancer cell or as a reporter, a targeting peptide which targets cancer cells in tissue to be treated such that binding of the protocell to the targeted cells is specific and enhanced and a fusogenic peptide that promotes endosomal escape of protocells and encapsulated DNA. Protocells according to the present invention may be used to treat cancer, especially including hepatocellular (liver) cancer using novel binding peptides (c-MET peptides) which selectively bind to hepatocellular tissue or to function in diagnosis of cancer, including cancer treatment and drug discovery.
-
公开(公告)号:US09731088B2
公开(公告)日:2017-08-15
申请号:US14739738
申请日:2015-06-15
Applicant: STC.UNM
Inventor: Nicola Jeanne Maynard , Hugh D. C. Smyth
CPC classification number: A61M15/0086 , A61M11/003 , A61M15/00 , A61M15/0006 , A61M15/0021 , A61M15/003 , A61M15/0035 , A61M15/009 , A61M2016/0015 , A61M2202/064 , A61M2205/0272 , A61M2205/8287 , A61M2206/16
Abstract: A dry powder delivery device may be configured to provide micronized dry powder particles to airways of a user. The device may include a cylindrical container delimiting a chamber containing at least one magnetically-responsive object, a motor external to said chamber, a magnet external to the chamber and rotatably coupled with the motor, and an outflow member configured to direct airflow to a user. The magnetically-responsive object may be coated with micronized dry powder particles, and the motor may be operable to rotate the magnet about an axis. Rotation of the magnet creates a magnetic field that causes the magnetically-responsive object to move in response to the magnetic field and collide with a side wall of the container to deaggregate the dry powder particles and aerosolize the dry powder in the chamber.
-
公开(公告)号:US09726472B1
公开(公告)日:2017-08-08
申请号:US14552016
申请日:2014-11-24
Applicant: STC.UNM
Inventor: Jean-Claude Diels , Ladan Arissian
CPC classification number: G01B9/02049 , G01B9/02015 , G02F1/39 , H01S3/0014 , H01S3/06712 , H01S3/082 , H01S3/086 , H01S3/106 , H01S3/1062 , H01S3/1083 , H01S3/1118
Abstract: Apparatus, systems, and methods of operating a fiber laser having polarization-preserving fibers can be applied as a sensor to detect a physical quantity. In various embodiments, polarization-preserving fibers can provide a laser cavity having an interferometer disposed in the laser cavity. In various embodiments, a fiber optical parametric oscillator can include an interferometer disposed in the cavity of the optical parametric oscillator. Additional apparatus, systems, and methods are disclosed.
-
公开(公告)号:US20170207599A1
公开(公告)日:2017-07-20
申请号:US15410406
申请日:2017-01-19
Applicant: STC.UNM
Inventor: Ravinder K. Jain
CPC classification number: H01S3/302 , G02B6/02138 , G02B6/02142 , H01S3/0675 , H01S3/08086 , H01S3/094042 , H01S3/094046 , H01S3/094096 , H01S3/09415 , H01S3/1003 , H01S3/1028 , H01S3/1053
Abstract: Improved Raman Fiber Laser (RFL) generators may include a mid-infrared fiber, e.g., a fiber comprising a tellurite glass, a chalcogenide glass, a fluoride glass, or similar material. A phase-shifted fiber Bragg grating may be inscribed in the fiber. A pump laser generator may be coupled with the fiber in order to supply a pump laser to the fiber. When stimulated by the pump laser, the RFL generator may emit an output laser having a mid-infrared wavelength. A tuner may be used to tune the output laser.
-
公开(公告)号:US20170184581A1
公开(公告)日:2017-06-29
申请号:US15411576
申请日:2017-01-20
Applicant: STC.UNM , SANDIA CORPORATION
Inventor: Richard S. Larson , Brian Hjelle , Pam R. Hall , David C. Brown , Marco Bisoffi , Susan M. Brozik , Darren W. Branch , Thayne L. Edwards , David Wheeler
IPC: G01N33/543 , G01N33/553 , G01N29/032 , C12Q1/68
CPC classification number: G01N33/54373 , C12Q1/6825 , G01N29/032 , G01N33/553 , G01N2291/0422
Abstract: Viruses and other bioagents are of high medical and biodefense concern and their detection at concentrations well below the threshold necessary to cause health hazards continues to be a challenge with respect to sensitivity, specificity, and selectivity. Ideally, assays for accurate and real time detection of viral agents and other bioagents would not necessitate any pre-processing of the analyte, which would make them applicable for example to bodily fluids (blood, sputum) and man-made as well as naturally occurring bodies of water (pools, rivers). We describe herein a robust biosensor that combines the sensitivity of surface acoustic waves (SAW) generated at a frequency of 325 MHz with the specificity provided by antibodies and other ligands for the detection of viral agents. In preferred embodiments, a lithium tantalate based SAW transducer with silicon dioxide waveguide sensor platform featuring three test and one reference delay lines was used to adsorb antibodies directed against Coxsackie virus B4 or the negative-stranded category A bioagent Sin Nombre virus (SNV), a member of the genus Hantavirus, family Bunyaviridae, negative-stranded RNA viruses. Rapid detection (within seconds) of increasing concentrations of viral particles was linear over a range of order of magnitude for both viruses, although the sensor was approximately 50×104-fold more sensitive for the detection of SNV. For both pathogens, the sensor's selectivity for its target was not compromised by the presence of confounding Herpes Simplex virus type 1. The biosensor was able to detect SNV at doses lower than the load of virus typically found in a human patient suffering from hantavirus cardiopulmonary syndrome (HCPS). Further, in a proof-of-principle real world application, the SAW biosensor was capable of selectively detecting SNV agents in complex solutions, such as naturally occurring bodies of water (river, sewage effluent) without analyte pre-processing.
-
公开(公告)号:US20170183663A1
公开(公告)日:2017-06-29
申请号:US15395233
申请日:2016-12-30
Applicant: STC.UNM
Inventor: Anatoliy Markiv , Ravi Venkata Durvasula , Angray Singh Kang
CPC classification number: C12N15/62 , A61K49/0045 , A61K49/0058 , A61N5/062 , C07K14/001 , C07K16/18 , C07K16/30 , C07K16/32 , C07K2317/62 , C07K2317/622 , C07K2319/00 , C07K2319/60 , C12N15/63 , C12Q1/04 , G01N33/53 , G01N33/582
Abstract: Embodiments of the present invention provide for the facile generation of a stable recombinant fusion polypeptides with intrinsic fluorescent properties. The recombinant antibodies may be suitable for qualitative and/or quantitative immunofluorescence analysis. Generally, the fluorescent polypeptides include a fluorescent domain comprising a C-terminus and an N-terminus; a first antibody domain covalently linked to the C-terminus; and a second antibody domain covalently linked to the N-terminus.
-
公开(公告)号:US20170172450A1
公开(公告)日:2017-06-22
申请号:US15123867
申请日:2015-03-06
Inventor: Eugene KOAY , Vittorio CRISTINI , Jason FLEMING , Priya BHOSALE , Christopher CRANE , Haifa SHEN , Mauro FERRARI
CPC classification number: A61B5/055 , A61B5/4233 , A61B5/425 , A61B5/4842 , A61B5/4848 , A61B6/032 , A61B6/12 , A61B6/481 , A61B6/5217 , A61B2576/00 , A61K49/0002 , G01R33/5601 , G06T7/0016 , G06T2207/10081 , G06T2207/10088 , G06T2207/30096
Abstract: Disclosed are method of detecting or characterizing a tumor by quantitatively measuring and comparing changes in mass transfer into the tumor and normal tissue over time using computed tomography or magnetic resonance imaging. The methods can be used to predict therapeutic response to treatment and to develop treatment plans.
-
-
-
-
-
-
-
-
-